Thursday, September 20, 2018
 
 
Company News: Page (1) of 1 - 04/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences
• Bemcentinib active in pre-clinical models of IPF and NASH• IPF and cirrhotic NASH patients with aggressive disease identified by AXL blood based biomarker• BGB601 (partnered AXL ADC drug candidate) ...
(April 13, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Medicine,Disease,Cancer,Surgery,Medication,Womens Health,Science,Lifestyle,Medical,Biology,Cancer,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines